|
Completed
|
NCT04573309 -
Copper and Molybdenum Balance in Participants With Wilson Disease Treated With ALXN1840
|
Phase 2 |
|
Completed
|
NCT03539952 -
Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease
|
Phase 3 |
|
Active, not recruiting
|
NCT04884815 -
Study of UX701 Gene Transfer for the Treatment of Wilson Disease
|
Phase 1/Phase 2 |
|
Not yet recruiting
|
NCT03659331 -
A Controlled Study of Potential Therapeutic Effect of Oral Zinc in Manifesting Carriers of Wilson Disease
|
N/A |
|
Recruiting
|
NCT05687474 -
Baby Detect : Genomic Newborn Screening
|
|
|
Terminated
|
NCT05047523 -
Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease
|
Phase 3 |
|
Completed
|
NCT04526210 -
Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants
|
Phase 1 |
|
Completed
|
NCT00004338 -
Study of Zinc for Wilson Disease
|
Phase 4 |
|
Enrolling by invitation
|
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
|
|
Completed
|
NCT02273596 -
Efficacy and Safety Study of WTX101 (ALXN1840) in Adult Wilson Disease Patients
|
Phase 2 |
|
Completed
|
NCT02763215 -
The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment
|
|
|
Recruiting
|
NCT05444127 -
Oral Health and Wilson's Disease: SOMAWI
|
|
|
Completed
|
NCT04408300 -
Study of Retinal Vascular Parameters in Patients With Wilson's Disease
|
N/A |
|
Recruiting
|
NCT05783687 -
Real World Evidence Study in Subjects With Wilson's Disease
|
|
|
Terminated
|
NCT04909346 -
Adeno-Associated Virus (AAV) Antibody Study in Subjects OTC Deficiency, GSDIa, and Wilson Disease
|
|
|
Completed
|
NCT03867526 -
Establishment of Human Cellular Disease Models for Wilson Disease
|
|
|
Enrolling by invitation
|
NCT03589820 -
Plasma Exchange and Continuous Hemodiafiltration in Treatment of Wilson's Disease-related Liver Failure
|
N/A |
|
Completed
|
NCT04526197 -
Phase 1 Study of ALXN1840 on the Metabolism of a CYP2C9 Substrate in Healthy Participants.
|
Phase 1 |
|
Completed
|
NCT04910581 -
rTMS in Wilson Disease Dysarthria
|
N/A |
|
Active, not recruiting
|
NCT02426905 -
Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine
|
Phase 4 |